Both in Pharmaceuticals
GRI Bio vs 60 Degrees Pharmaceuticals
Over the past year GRI returned −96.4% and SXTP returned −79.7%; their daily moves had a correlation of 0.03.
GRI −96.4% SXTP −79.7%Growth of $1, one year, split-adjusted
| Metric | GRI | SXTP |
|---|---|---|
| Price | $2.00 | $1.25 |
| Market cap | $4.4M | $4.4M |
| Today | −4.76% | 0.00% |
| 1 month | +4.2% | +21.4% |
| 6 months | −11.5% | −17.2% |
| Year to date | −71.1% | −38.5% |
| 1 year | −96.3% | −77.0% |
| Revenue growth (YoY) | — | −32.5% |
| Gross margin | — | 27.3% |
| Net margin | — | −1152.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 3.6× |
| Net cash | $10.9M | $873.4K |
| Dividend yield | — | — |
| Volatility (60d) | 132.4% | 76.7% |
| Short % of float | 6.8% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).